Skip to main content
OpenTrials

Clinical trial condition

Breast Neoplasms

Explore clinical trials studying Breast Neoplasms. Study availability and eligibility vary by location and protocol.

9,742 public trials 1,775 recruiting studies
Refine in advanced search Browse all conditions

Breast Neoplasms trial results

Recruiting

A Study of SIM0270 Combined With Everolimus vs. Treatment of Physician's Choice in Patients With ER+/HER2- Advanced Breast Cancer (SIMRISE)

NCT06680921

Conditions
Breast Diseases, Breast Neoplasms, Locally Advanced or Metastatic Breast Cancer, +4 more
Locations
  • The First Affiliated Hispital of Bengbu Medical University Bengbu, Anhui, China
  • Anhui Provincial Cancer Hospital Hefei, Anhui, China
  • The First Affiliated Hispital of Anhui Medical University Hefei, Anhui, China
  • Maanshan People's Hospital Maanshan, Anhui, China
View all 60 locations
View Trial Details
Recruiting

First-in-Human Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, as a Single Agent in Patients With Advanced Solid Tumors and in Combination With Endocrine Therapy +/- a CDK4/6 or CDK4 Inhibitor in Patients With Advanced Solid Tumors or Advanced Breast Cancer

NCT05216432

Conditions
Advanced Breast Cancer, Breast Cancer, Breast Diseases, +10 more
Locations
  • The University of Arizona Cancer Center Tucson, Arizona, United States
  • University of California-San Diego San Diego, California, United States
  • HealthONE Denver, Colorado, United States
  • Yale University New Haven, Connecticut, United States
View all 37 locations
View Trial Details
Recruiting

Remotely Supervised Computerized Cognitive Stimulation to Reduce Post-chemotherapy Cognitive Difficulties in Patients Treated for Localized Breast Cancer

NCT06027632

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +8 more
Locations
  • Polyclinique Bordeaux Nord Aquitaine Bordeaux, France
  • Centre hospitalier de Bligny Briis-sous-Forges, France
  • Centre François Baclesse Caen, France
  • CH Métropole Savoie Chambéry, France
View all 25 locations
View Trial Details
Recruiting

TRUDI: TDXD+Durva in HER2+/Low IBC

NCT05795101

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +9 more
Locations
  • Brigham and Women's Hospital Boston, Massachusetts, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • University of Texas MD Anderson Cancer Center Houston, Texas, United States
View Trial Details

Related conditions